Article Sidebar

PDF
Date Published: 17/02/2023
Abstract Views: 281
Views PDF: 1227
DOI: https://doi.org/10.51298/vmj.v520i2.4127
Issue
Vol. 520 No. 2 (2022)
Section
Các bài báo
How to Cite
Lê, T. Đạt, & Nguyễn, T. T. T. (2023). CLINICAL CHARACTERISTICS OF PATIENTS WITH GRAVES’ OPHTHALMOPATHY AT THE DEPARTMENT OF TRADITIONAL MEDICINE - NATIONAL HOSPITAL OF ENDOCRINOLOGY. Vietnam Medical Journal, 520(2). https://doi.org/10.51298/vmj.v520i2.4127

CLINICAL CHARACTERISTICS OF PATIENTS WITH GRAVES’ OPHTHALMOPATHY AT THE DEPARTMENT OF TRADITIONAL MEDICINE - NATIONAL HOSPITAL OF ENDOCRINOLOGY

Tiến Đạt Lê1, Thị Thanh Tú Nguyễn1,
1 Hanoi medical university

Main Article Content

Abstract

Objective: This study aimed to describe the clinical features of patients with Graves’ ophthalmopathy (GO) at the Department of Traditional Medicine of National Hospital of Endocrinology from August 2021 to August 2022. Subjects and Method: This study was designed as a cross-sectional descriptive study. 60 patients with confirmed diagnosis of GO were enrolled in the study. Results: The study results showed that the patients aged 36-50 years old accounted for 41.7%, the mean age was 40.85 ± 12.63 years old. The proportion of female patients was higher than that of male (ratio of women:men ≈ 4:1). The patients having disease’s duration from 6 to 12 months accounted for 55%. Most of the patients had lesions in both eyes. The mean CAS (Clinical activity score) was 3.45 ± 0.72. The mean severity index of exophthalmos was 19.18 ± 0.62 (mm). The mean level of upper eyelid muscle contraction was 1.43 ± 0.50 (mm). The proportion of patients with double vision was 40%. The average GO-QoL (Graves ophthalmopathy-quality of life) score was 30.33 ± 1.31.

Article Details

Keywords

Graves’ ophthalmopathy (GO), Thyroid-associated Ophthalmopathy (TAO), European Group on Graves’ Orbitopathy (EUGOGO)

References

1. Cục quản lý Khám chữa bệnh. Quy trình chuyên môn chẩn đoán, điều trị và chăm sóc người bệnh Basedow. 11
2. Hứa Căn Quý, Ngô Nghệ Quân, Thịnh Văn, Chu Tú Ảnh, Lã Phàm. Mối tương quan giữa các yếu tố ảnh hưởng lên thị giác trên bệnh nhãn khoa có liên quan tới tuyến giáp. Tạp chí khoa học và nhãn khoa Trung Quốc. 2013; 015 (002): P.98-1031 1
3. Hà Kim Sâm, Tôn Khắc Hưng, Ngụy Kiến Tử, Vương Tĩnh. Nghiên cứu lâm sàng về châm cứu trong điều trị bệnh mắt liên quan tới cường giáp. Học báo học viện Trung y Phúc Kiến. 2001. 11(4): 23
4. Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158(3):273-285.
5. Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol. 2021;185(4):G43-G67.
6. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121(3):284-290.
7. Kalmann R, Mourits MP. Late recurrence of unilateral graves orbitopathy on the contralateral side. Am J Ophthalmol. 2002;133(5):727-729.
8. Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf). 1996;45(4):477-481.
9. Prummel MF, Bakker A, Wiersinga WM, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: the first European Group on Graves’ Orbitopathy experience. Eur J Endocrinol. 2003;148(5):491-495.
10. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid Off J Am Thyroid Assoc. 2002;12(10):855-860.